References
Dooley M, Jarvis B. Iomeprol. A review of its use as a contrast medium. Drugs 2000 May; 59(5): 1169–1186
Almén T. The etiology of contrast medium recations. Invest Radiol 1994; 29 Suppl. 1: S37–S45
McClellan B, Stolberg H. Intravascular contrast media. Ionic versus nonionic: current status. Radiol Clin North Am 1991 May; 29(3): 437–54
Fattori R, Piva R, Schicchi F, et al. Iomeprol and iopamidol in cardiac angiography: a randomised, double-blind, parallel-group comparison. Eur J Radiol 1994 May; 18 Suppl. 1: S61–66
Morris TW. X-ray contrast media: where are we now, and where are we going? Radiology 1993; 188(1): 11–6
Gallotti A, Uggeri F, Favilla A, et al. The chemistry of iomeprol and physico-chemical properties of its aqueous solutions and pharmaceutical formulations. Eur J Radiol 1994; 18 Suppl. 1: S1–S12
Schräder R, Esch I, Ensslen R, et al. A randomized trial comparing the impact of a nonionic (omeprol) versus an ionic (ioxaglate) low osmolar contrast medium on abrupt vessel closure and ischemic complications after coronary angioplasty. J Am Coll Cardiol 1999 Feb; 33: 395–402
Dacaronias D, Minguzzi P, Ugolotti U, et al. Iomeprol vs iopamidol in intraarterial peripheral digital subtraction angiography. Angiology 1992 Sep; 43: 734–40
Imai H, Hiruma H, Kumazaki T, et al. Effect of low-osmolality contrast media on red cell filterability. Acta Radiol 1993 May; 34: 214–9
Bracco S.p.a. Iomeron prescribing information. Milan, Italy, 1999
Schmiedel E. Are the tolerabilities of nonionic contrast media identical? The results of a double-blind randomised multicentre study with iomeprol and iopramide [in German] Aktuelle Radiol 1997; 7(4): 183–8
Harding JR, Bertazzoli M, Spinazzi A, A randomized, double-blind, parallel group trial of iomeprol, iohexol and iopamidol in intravenous urography. Br J Radiol 1995 Jul; 68: 712–5
Radensky PW, Cahill NE. Universal use of low-osmolality contrast media for the 1990s. Radiology 1997; 203(2): 310–1
Rights and permissions
About this article
Cite this article
Iomeprol — a promising new nonionic contrast medium. Drugs Ther. Perspect 17, 1–4 (2001). https://doi.org/10.2165/00042310-200117120-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-200117120-00001